sars-cov-2 | ABS-CBN News

ABS-CBN News
  • facebook
  • twitter
  • youtube
  • login
  • Home
  • News
  • Business
  • Entertainment
  • Life
  • Sports
  • Overseas
  • Spotlight
  • Weather
  • TV Patrol
  • TELERADYO
  • TFC
  • ANC
  • ANCX

Topic: sars-cov-2

WHO chief to 'push until we get the answer' on Covid origins

WHO chief to 'push until we get the answer' on Covid origins

Nina Larson, Agence France-Presse
Posted at Feb 16 02:40 AM

Solving the mystery of where the SARS CoV-2 virus came from and how it began spreading among humans is considered vital for averting future pandemics. Read more »

WHO estimates 90 pct have some resistance to COVID-19

WHO estimates 90 pct have some resistance to COVID-19

Agence France-Presse
Posted at Dec 03 09:54 AM

Gaps in vigilance were leaving the door open for a new virus variant to appear and overtake the globally dominant omicron, said WHO director-general Tedros Adhanom Ghebreyesus. Read more »

WHO urges countries to continue COVID testing, surveillance

WHO urges countries to continue COVID testing, surveillance

Raphael Bosano, ABS-CBN News
Posted at Jun 16 07:35 PM

WHO reminds countries to maintain good COVID-19 testing and surveillance in order not to lose track of the movement and evolution of the virus. Read more »

UK COVID patient was positive for record 505 days: researchers

UK COVID patient was positive for record 505 days: researchers

Agence France-Presse
Posted at Apr 25 07:13 AM

British researchers believe they have documented the longest-known Covid-19 infection, in a patient who tested positive for a total of 505 days before their death. Read more »

COVID and flu co-infection raises risk of severe illness, death

COVID and flu co-infection raises risk of severe illness, death

Nancy Lapid, Reuters
Updated as of Mar 29 07:33 AM

Having COVID-19 and influenza at the same time puts hospitalized adults at much greater risk of critical illness and death. Read more »

Variant that combines Delta and Omicron identified

Variant that combines Delta and Omicron identified

Nancy Lapid, Reuters
Posted at Mar 11 07:31 AM

Hybrid versions of the coronavirus that combine genes from the Delta and Omicron variants - dubbed "Deltacron" - have been identified in at least 17 patients in the United States and Europe, researchers said. Read more »

Almost a third of people report lingering symptom 6-12 months after COVID-19 - study

Almost a third of people report lingering symptom 6-12 months after COVID-19 - study

Jennifer Rigby, Reuters
Posted at Mar 05 04:26 AM

New diagnoses of anxiety and depression were also more common among those with a history of SARS-CoV-2 infection, the study showed. Read more »

World's 1st trial deliberately infecting young adults with COVID found to be safe

World's 1st trial deliberately infecting young adults with COVID found to be safe

Reuters
Posted at Feb 02 07:44 PM

The trial infected 36 healthy male and female volunteers aged 18-29 years with the original SARS-CoV-2 strain of the virus. Read more »

Scientists on alert over rising cases caused by Omicron cousin BA.2

Scientists on alert over rising cases caused by Omicron cousin BA.2

Reuters
Posted at Jan 31 06:34 AM

The highly transmissible Omicron variant of the SARS-CoV-2 virus - the most common form of which is known as BA.1 - now accounts for nearly all of the coronavirus infections globally. Read more »

Studies highlight need for boosters to fight omicron

Studies highlight need for boosters to fight omicron

Julie Steenhuysen, Reuters
Posted at Jan 22 07:33 AM

The studies, led by the CDC, are among the first in the United States to look at the impact of booster doses against the fast-spreading omicron. Read more »

T-cells from common colds can provide protection vs COVID - study

T-cells from common colds can provide protection vs COVID - study

Alistair Smout, Reuters
Posted at Jan 10 07:00 PM

Current COVID-19 vaccines target the spike protein, which mutates regularly. Read more »

Isolation and innovation: 2 years of the COVID-19 pandemic

Isolation and innovation: 2 years of the COVID-19 pandemic

Paul Ricard, Agence France-Presse
Updated as of Jan 06 02:57 PM

Two years ago, a previously unknown virus plunged humanity into an unprecedented global crisis that has transformed our daily lives -- and significantly expanded scientific knowledge. Read more »

Virus leaves antibodies that may attack healthy tissue: study

Virus leaves antibodies that may attack healthy tissue: study

Nancy Lapid, Reuters
Updated as of Jan 04 07:40 AM

Months after recovering from SARS-CoV-2 infection, survivors have elevated levels of antibodies that can mistakenly attack their own organs and tissues, even if they had not been severely ill, according to new findings. Read more »

Coronavirus can stay in body for months, US study finds

Coronavirus can stay in body for months, US study finds

South China Morning Post
Posted at Dec 27 07:54 AM

The coronavirus that causes Covid-19, Sars-CoV-2, can spread within days from the airways to the heart, brain and almost every organ system in the body, where it may persist for months. Read more »

AstraZeneca: 3rd jab 'significantly' boosts Omicron antibodies

AstraZeneca: 3rd jab 'significantly' boosts Omicron antibodies

Agence France-Presse
Posted at Dec 23 06:03 PM

AstraZeneca said that a third, or "booster", dose of its COVID-19 vaccine "significantly" lifted antibody levels against Omicron in a study. Read more »

Experimental saliva test nearly as accurate as PCR

Experimental saliva test nearly as accurate as PCR

Nancy Lapid, Reuters
Posted at Dec 09 08:49 AM

An experimental saliva test can diagnose SARS-CoV-2 infection in minutes, nearly as accurately as gold-standard PCR tests. Read more »

Omicron variant may have picked up a piece of common-cold virus

Omicron variant may have picked up a piece of common-cold virus

Nancy Lapid, Reuters
Updated as of Dec 06 11:43 AM

The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus - possibly one that causes the common cold. Read more »

Flu jabs may aid COVID-19 patients who need surgery

Flu jabs may aid COVID-19 patients who need surgery

Nancy Lapid, Reuters
Posted at Oct 26 07:52 AM

COVID-19 patients who require surgery appear to face fewer complications if they have previously been vaccinated against the flu, new data suggest. Read more »

COVID-19: What are we ignoring?

COVID-19: What are we ignoring?

Dean Dela Paz
Posted at Sep 28 11:58 PM

The reasons are legion. From deploying the wrong officials to ineffective contact-tracing, to employing a singular measure for a multi-dimensional mutating problem, to ignoring the pandemic’s latent demands and deliberately diverting billions to enrich peddlers. Read more »

Sinovac jab less effective against Gamma variant: study

Sinovac jab less effective against Gamma variant: study

ABS-CBN News
Posted at Jul 09 07:32 AM

PARIS, France - The Chinese CoronaVac jab, also known as the Sinovac COVID-19 vaccine, is less effective against the Gamma variant first detected in virus-ravaged Brazil, a study said Friday. Read more »

12345 > Last
  • LATEST NEWS
  • MOST READ
  • Palace suspends afternoon gov't work on April 5

  • Blackpink's Jisoo blooms in solo debut album 'ME'

  • LOOK: Janella Salvador turns 25 with new sizzling photos

  • 3 National Artists headline CCP's Performatura Festival

  • Deaths in India temple tragedy climb

  • Ilang apektado ng oil spil naghain na compensation claim

  • Star Magic announces upcoming events for the year

  • Ending the month with a high

  • BI vows to improve inspection practices

  • Jodi, Joshua, Gabbi get entangled in 'Unbreak My Heart' trailer

  • ALAMIN: Mga impormasyong kinukuha ng Immigration sa biyahero

  • Pinakamalaking catamaran ferry sa buong mundo, gawang Pinoy

  • How climate change inaction can hurt developing economies

  • Marcos says to work harder to uplift Pinoys’ lives

  • ICYMI: G! Kapamilya concert sa Abu Dhabi dinumog

© 2023 ABS-CBN Corporation. All Rights Reserved.

AboutCareersPrivacyTermsContact UsAdvertise With Us